Moderna Reports $966M Q4 2024 Revenue Amid COVID-19 Vaccine Decline, Focuses on mRNA Pipeline Expansion

Financial Performance Overview Moderna reported Q4 2024 revenue of $966 million, marking a 66% decline year-over-year (...

February 17, 2025 | Monday | Company results
GSK Reports Strong Q4 2024 Growth in Specialty Medicines and HIV, Offsetting Vaccine Declines

GSK delivered a strong performance in Q4 2024, with total sales reaching £8.12 billion, reflecting a 4% year-over-...

February 17, 2025 | Monday | Company results
Eli Lilly Reports Record Q4 2024 Revenue of $13.53B, Fueled by Mounjaro, Zepbound, and Oncology Growth

Eli Lilly & Co. reported a strong financial performance in Q4 2024, with substantial revenue growth driven by its bl...

February 17, 2025 | Monday | Company results
Biogen Reports Q4 and Full-Year 2024 Results: Strong EPS Growth Amid Revenue Challenges

Key Financial Highlights Biogen Inc. reported its fourth-quarter (Q4) and full-year 2024 results on February 12, 2025. ...

February 17, 2025 | Monday | Company results
AstraZeneca Reports Strong Q4 2024 Growth with $14.89 Billion Revenue, Driven by Oncology and Innovative Therapies

  AstraZeneca delivered a strong performance in Q4 2024, with Total Revenue reaching $14.89 billion, marking a 24%...

February 17, 2025 | Monday | Company results
Korea's Hanmi Pharma introduces new automated vial dispensing solution in Canada and US

South Korea-based Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significant strides ...

February 15, 2025 | Saturday | News
Qiagen strengthens global bioinformatics leadership with new centre in APAC region

Qiagen has announced the official opening of a new data centre in Melbourne, Australia, designed to strengthen its globa...

February 14, 2025 | Friday | News
Korea's SK bioscience collaborates with WHO to strengthen infectious disease response

South Korea-based SK bioscience has announced that it is the only private company to participate in the World Health Org...

February 12, 2025 | Wednesday | News
Australian startup ENA Respiratory secures $5M to develop nasal powder against viral infections

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimise ...

February 12, 2025 | Wednesday | News
Zydus and Synthon to commercialise novel 505(B)(2) oncology product in US market

India-based Zydus Lifesciences (including its subsidiaries and affiliates), has signed an exclusive development, licensi...

February 12, 2025 | Wednesday | News
Bio X Cell expands global reach with new distribution centre in China

Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its globa...

February 13, 2025 | Thursday | News
Australia's AdvanCell partners with Lilly to develop new targeted alpha therapies for cancer treatment

AdvanCell, a radiopharmaceutical company specialising in targeted alphaherapias, has announced the expansion of the scop...

February 11, 2025 | Tuesday | News
OliX Pharma and Lilly to develop treatment for metabolic-associated steatohepatitis

South Korea-based OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced a global licensing...

February 10, 2025 | Monday | News
Japan's PHC partners with CCRM in Canada to develop primary T-cell expansion culture processes

Japan-based PHC Corporation has signed a Master Collaboration Agreement with CCRM (based in Canada) to work together on ...

February 10, 2025 | Monday | News
Korean firm LG to develop AI model for protein multistate structure prediction

LG AI Research recently signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,&...

February 9, 2025 | Sunday | News
Bain Capital to acquire Mitsubishi Tanabe Pharma Corporation for $3.3 B

Bain Capital, a leading global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe P...

February 6, 2025 | Thursday | News
Dr. Reddy’s Lab inks oncology deal of $131 M with Shanghai Henlius Biotech

Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of India-based Dr. Reddy’s Laboratories Ltd. has entere...

February 6, 2025 | Thursday | News
BD announces intent to separate biosciences and diagnostic solutions business

BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in the US, has announ...

February 6, 2025 | Thursday | News